Global Alvimopan Market Growth 2025-2031
Description
The global Alvimopan market size is predicted to grow from US$ million in 2025 to US$ million in 2031; it is expected to grow at a CAGR of %from 2025 to 2031.
Alvimopan, CAS 156053-89-3, (trade name Entereg) is a drug, which behaves as a peripherally acting μ-opioid receptor antagonist. It is currently only Food and Drug Administration approved for the treatment of postoperative ileus, which it received in May 2008.
Alvimopan (CAS 156053-89-3) is widely used in Pharmaceutical and Other field. The most proportion of Alvimopan (CAS 156053-89-3) is used in Pharmaceutical, and the proportion in 2019 is 88.64%. Market competition is intense. Merck is the leaders of the industry, and they hold key technologies and patents, with high-end customers.
LP Information, Inc. (LPI) ' newest research report, the “Alvimopan Industry Forecast” looks at past sales and reviews total world Alvimopan sales in 2024, providing a comprehensive analysis by region and market sector of projected Alvimopan sales for 2025 through 2031. With Alvimopan sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Alvimopan industry.
This Insight Report provides a comprehensive analysis of the global Alvimopan landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Alvimopan portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Alvimopan market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Alvimopan and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Alvimopan.
This report presents a comprehensive overview, market shares, and growth opportunities of Alvimopan market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
Pharmaceutical Grade
Others
Segmentation by Application:
Pharmaceutical
Other
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.
Merck
Teva Pharmaceutical Industries Ltd
MSN Life Sciences Private Ltd
Key Questions Addressed in this Report
What is the 10-year outlook for the global Alvimopan market?
What factors are driving Alvimopan market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Alvimopan market opportunities vary by end market size?
How does Alvimopan break out by Type, by Application?
Please note: The report will take approximately 2 business days to prepare and deliver.
Alvimopan, CAS 156053-89-3, (trade name Entereg) is a drug, which behaves as a peripherally acting μ-opioid receptor antagonist. It is currently only Food and Drug Administration approved for the treatment of postoperative ileus, which it received in May 2008.
Alvimopan (CAS 156053-89-3) is widely used in Pharmaceutical and Other field. The most proportion of Alvimopan (CAS 156053-89-3) is used in Pharmaceutical, and the proportion in 2019 is 88.64%. Market competition is intense. Merck is the leaders of the industry, and they hold key technologies and patents, with high-end customers.
LP Information, Inc. (LPI) ' newest research report, the “Alvimopan Industry Forecast” looks at past sales and reviews total world Alvimopan sales in 2024, providing a comprehensive analysis by region and market sector of projected Alvimopan sales for 2025 through 2031. With Alvimopan sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Alvimopan industry.
This Insight Report provides a comprehensive analysis of the global Alvimopan landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Alvimopan portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Alvimopan market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Alvimopan and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Alvimopan.
This report presents a comprehensive overview, market shares, and growth opportunities of Alvimopan market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
Pharmaceutical Grade
Others
Segmentation by Application:
Pharmaceutical
Other
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.
Merck
Teva Pharmaceutical Industries Ltd
MSN Life Sciences Private Ltd
Key Questions Addressed in this Report
What is the 10-year outlook for the global Alvimopan market?
What factors are driving Alvimopan market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Alvimopan market opportunities vary by end market size?
How does Alvimopan break out by Type, by Application?
Please note: The report will take approximately 2 business days to prepare and deliver.
Table of Contents
76 Pages
- *This is a tentative TOC and the final deliverable is subject to change.*
- 1 Scope of the Report
- 2 Executive Summary
- 3 Global by Company
- 4 World Historic Review for Alvimopan by Geographic Region
- 5 Americas
- 6 APAC
- 7 Europe
- 8 Middle East & Africa
- 9 Market Drivers, Challenges and Trends
- 10 Manufacturing Cost Structure Analysis
- 11 Marketing, Distributors and Customer
- 12 World Forecast Review for Alvimopan by Geographic Region
- 13 Key Players Analysis
- 14 Research Findings and Conclusion
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
